Week in review for Feb. 24-28, 2020: Two migraine therapies approved March 2, 2020 By Peter Winter A quick look back at top stories, including: 1st Biotherapeutics, Acacia, Apeiron, Ascletis, Axovant, Bicycle, Biogen, Biohaven, Boehringer Ingelheim, Cocrystal, Curis, Glaxosmithkline, H. Lundbeck, Makscientific, MPM, NGM, Oramed, Pvp, Redhill, Roche, Sangamo, Shenzhen Xtalpi, Sichuan Clover, Steba, Takeda, Tetra, Tonix, Trutino, Twoxar, Vir, Wuxi.Read More
Biopharma money raised: Jan. 1-Feb. 27, 2020 Feb. 28, 2020 Year-to-date money raised in public, private and other financings of biopharma companies.Read More
Money raised by biopharma: 2020 vs. 2019 Feb. 28, 2020 Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.Read More
Collaborations between biopharmaceutical companies and government/nonprofit entities: January 2020 Feb. 28, 2020 Deals between biopharma companies and government or nonprofit entities, including: Actinium, Angiogenex, Axovant, Bellicum, Bicycle, Canonic, Celgene, Chongqing Zhifei, Cytovia, Decibel, Dinaqor, Diomics, Eagle, Ervaxx, G1, Gene Techno, Genentech, Genethon, Gilead, GSK, Horizon, Hoth, Medigene, Microcures, Moderna, Novartis, Oncotartis, Onxeo, Opiant, Orion, Sapphire, Tacitus, Titan, Valneva, Yposkesi, Zyus.Read More
Collaborations between biopharmaceutical companies and government/nonprofit entities: February 2020 Feb. 28, 2020 Deals between biopharma companies and government or nonprofit entities, including: AB Biotics, ACT Genomics, Advent, Agex, Be Cool, Benevolentai, Beroni, Biomarin, Bridge, Chugai, CNS, Cocrystal, Dianomi, Enochian, Entourage Phytolab, Erytech, Evgen, Exicure, Genprex, Gibson Oncology, GSK, J&J, Novartis, Oncologie, Orgenesis, Sanofi Pasteur, Sapphire, Synspira, Theratechnologies, Toa Eiyo, VBL, WPD.Read More
Biopharmaceutical grants: January 2020 Feb. 28, 2020 Grants received by biopharma companies in January 2020.Read More
Biopharmaceutical grants: February 2020 Feb. 28, 2020 Grants received by biopharma companies in February 2020.Read More
Biggest gainers and losers for the week of Feb. 24-28, 2020 Feb. 28, 2020 The top 10 biopharma stock gainers and losers for the week.Read More
Med-tech gainers and losers for Feb. 24-28, 2020 Feb. 28, 2020 The top 10 med-tech stock gainers and losers for the week.Read More
Coronavirus outbreak brings focus on companies developing potential therapies Feb. 25, 2020 By Peter Winter The public attention that COVID-19 has received has spilled over to antibiotics companies, and the BioWorld Infectious Diseases index has grown 14% in value since the beginning of the year.Read More